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Introduction
Rhabdomyosarcoma (RMS) is a fast growing and highly malignant tumour 
of the soft tissue commonly affecting the head and neck.[1] It originates from 
mesenchymal tissue of highly myogenic differentiation of immature embryonic 
skeletal muscles.[2] This tumour accounts for 60% of sarcomas in children aged 
less than 5 years.[3, 1]  RMS of the head and neck are divided anatomically into 
two based on their origin as parameningeal or non-parameningeal with the 
former having the worst prognosis.[5, 6] RMS of the temporal bone is very rare.[4] 
The predisposition to RMS is thought to be genetic mutation either in the form 
of chromosomal translocation or allelic loss which subsequently contributes to 
the oncogenic characteristic of the tumour.[2]
RMS has three known pathological types namely, embryonal rhabdomyosarcoma 
(85%), alveolar rhabdomyosarcoma (15%) and pleomorphic rhabdomyosarcoma 
(anaplastic rhabdomyosarcoma and undifferentiated sarcoma) with the former 
being common in children.[1, 8, 9]
RMS almost always mimics complicated chronic suppurative otitis media 
(CSOM) with ear discharge and ear canal mass.  About 30% of patients have 
craniopathies at presentation. This may delay the diagnosis of RMS due to 
similarities in their clinical picture. The diagnosis of RMS is best confirmed 
through histopathology. Imaging is useful to determine the extent of disease.[11]
Multiple chemotherapy and radiation with or without tumour resection have 
greatly improved prognosis.[12] Ten percent of patients with RMS used to have 
a five years survival rate, but after the adoption of multi-modality therapy, 
outcomes were greatly improved.[11] Our three and half year-old male presented 
with features resembling a complicated CSOM, associated with facial weakness. 
The histopathology and immunostains of the ear polypoid mass were consistent 
with embryonal RMS.
Case presentation
A three and half year-old male was seen at Mulago National Referral Hospital, 
Embryonic rhabdomyosarcoma of the petrous 
bone in a child: a case report
Justin Rubena Lumaya,1 Mubarak 
Mohamed Dahir,2 Justin Namwangala3 
and Christopher Ndoleriire3
1. Consultant ENT, Ministry of Health, 
Juba Teaching Hospital, South Sudan
2. Consultant ENT, Ministry of Health, 
Hargeisa, Somaliland
3. Consultant ENT, Makerere University, 
Uganda
Correspondence:
Justin Rubena Lumaya 
lugela4@yahoo.com
Submitted: August 2019  
Accepted: April 2020 
Published: August 2020
Citation:
Lumaya et al. Embryonic rhabdomyosarcoma 
of the petrous bone in a child: a case 
report. South Sudan Medical Journal 
2020;13(3):112-115
© 2020 The Author (s)
License: This is an open access article 
under CC BY-NC-ND
Abstract
Rhabdomyosarcoma (RMS) is a cancer of skeletal muscle origin, and the second 
most common soft tissue sarcoma encountered in childhood. The head and 
neck are common sites though the temporal bone is rare. Rhabdomyosarcoma 
represents 3.5% of all malignancies in children aged 0-14 years, with 
approximately 250 new cases diagnosed each year. Despite the more intensive 
management modalities including surgery and combination chemo-radiation, 
the outcome for patients with metastatic disease remains poor. Here, we report 
a case of temporal bone Embryonic RMS in a three and half year-old male who 
was seen at Mulago National Referral Hospital, Kampala in 2016 and describe 
the clinical, radiological and histopathological presentation of relevance to 
RMS.
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Kampala in 2016. He presented with right ear discharge 
for a month, associated with swelling behind the ear and 
right facial weakness. The discharge was watery and blood 
stained later becoming purulent. He did not experience 
pain until a week prior to admission when the swelling 
behind the ear developed, associated with high fever. 
There were no convulsions. The mother noticed that 
the child’s right eye did not close completely, with facial 
weakness, and associated drooling of saliva. There was no 
relevant past history, no history of trauma and no contact 
with others with respiratory symptoms.
Examination revealed a generally sick child. There was 
no palpable cervical lymphadenopathy, however the right 
facial palsy and convergent squint of the right eye were 
obvious (Figure 1).
The right auricle was displaced anteriorly and downward 
with a diffuse tendered post auricular swelling.  The post-
auricular crease was intact.
The external auditory canal (EAC) was full of debris which 
was sucked out revealing a pale, fleshy mass occupying 
the entire canal with a serosanguinous discharge. The 
tympanic membrane could not be seen (Figure 2).
A biopsy from the aural mass showed clusters of small 
round cells with hyper chromatic nuclei and eosinophilic 
cytoplasm separated by fibro vascular septae consistent with 
embryonic rhabdomyosarcoma. Immunohistochemistry 
found desmin, smooth muscle actin and myogenin which 
are considered to be of diagnostic value. 
At first the suspicion was of complicated CSOM with an 
aural polyp. CT scan imaging is shown in Figures 3, 4a, 
4b, 5 and 6.
The best option for this case was chemotherapy (cisplatin 
and vincristine every week for 4 cycles) and local control 
with radiotherapy in view of involvement of vital structures 
and the intracranial extension. Unfortunately, after three 
weeks from admission between diagnosis and the planned 
management, the child died most likely from the effects 
of metastases.
Discussion
In 1854 Weber described rhabdomyosarcoma (RMS) as 
a malignant neoplasm of soft tissue arising from skeletal 
muscle most commonly affecting the head and neck, 
genitourinary tract although other organs can be affected.
[1] The incidence of RMS is more common in children 
between the ages of 1-4 years and accounts for 60% of 
soft tissue sarcomas in children.[3] It is considered to be 
the third commonest (35%) tumour in childhood after 
neuroblastoma and nephroblastoma with slight male 
preponderance.[4]
RMS of the head and neck is divided anatomically into 
two types: [6, 8]
1. Parameningeal- including the nose, nasopharynx, 
paranasal sinuses, mastoid region, infra-temporal, 
pterygopalatine fossae and middle ear.
2. Non-parameningeal- scalp, orbit, parotid gland, 
oral cavity, oropharynx and larynx 
RMS of the ear or temporal bone is very rare. However, 
it commonly occurs in the head and neck region with the 
orbit constituting about one-third of cases, followed by 
oral cavity and pharynx (29%), and the face and neck 
region (24%).[4] 
Figure 1. Right facial palsy and convergent squint of the right eye. Figure 2. A polypoid aural mass seen occupying the whole right 
external ear canal.
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RMS that arise from the middle ear, may begin either in the muscles near the 
eustachian tube, in the proper middle ear, or from primitive pluripotential 
mesenchymal rests. At the time of diagnosis, there is usually widespread local 
invasion throughout the petrous bone and the actual site of origin is often 
obscure.[13] In  two thirds of RMS cases arising from the middle ear there is 
already extensive bone erosion.[5,13] RMS of the head and neck with meningeal 
involvement carries  the worst prognosis.[5] In our case there was meningeal 
involvement and the site of origin  was not clear due to extensive destruction. 
The main predisposing factor for the development of an RMS is a genetic 
mutation associated with 2:13 or 1:13 chromosomal translocation which 
produce PAX3-FKHR and PAX7-FKHR fusion products, respectively. These 
translocations result in altered expression and consequently contribute to its 
oncogenic characteristics. This is particularly true for alveolar RMS while in 
most embryonal rhabdomyosarcoma cases there is allelic loss at chromosome 
11p15.[2]
Several pathological types of RMS have been described [1,8,9]:
1. Embryonal RMS (85%). This arises from the embryonic mesenchymal 
tissue in approximately 35% of all paediatric RMS of the head and 
neck.
2. Alveolar RMS (15%). Most often seen in older children characterized 
by faster growth than embryonic RMS and usually requires more 
intensive treatment. 
3. Anaplastic RMS and undifferentiated sarcoma (pleomorphic RMS) 
RMS usually presents with a triad of otitis media, bloody ear discharge and 
a polypoid mass in the external ear.  Less commonly there is an external 
mass behind the ear. Occasionally, paralysis or paresis of the facial nerve 
occurs.[12] Progression is rapid with involvement of the petrous apex, internal 
auditory canal, and skull base leading to other craniopathies, estimated at 
approximately 30% of patients at the time of diagnosis.[10] 
Middle ear inflammatory disease may be present at the same time, thus 
delaying the diagnosis and making total resection impossible in most cases. 
Chemotherapy and radiotherapy with or without tumour resection have 
resulted in improved prognosis.[12] 
There are three commonly used clinical staging systems for RMS:[11]
Figure 3. Pre-contrasted axial CT scans 
through the petrous part. Shows a soft tissue 
density mass in the petrous bone obliterating 
the external auditory canal. 
Figure 4a and 4b Axial sections shows heterogeneous enhancement of the mass. It is 
extending into the petrous apex.
Figure 6. Bone window of axial CT scans 
shows destruction of the temporal bone 
(tympanic, petrous, and mastoid and 
posterior part of the squamous part). 
There is erosion of the clivus, tegmen 
tympani and sphenoid bone.
Figure 5. Coronal CT scans showing intra-
cranial extension (extra-axial) of the mass 
with upward displacement of the overlying 
temporal lobe.
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1. IRS (Intergroup Rhabdomyosarcoma Study)
2. TNM, and
3. Clinical (surgico-pathologic).
The IRS classification includes four groups, based on 
whether the tumour can be resected:
i. Localized disease, tumour resected completely, 
regional lymph nodes not involved. Group I tumours 
have better prognosis
ii. Localized disease with microscopic residual disease 
or regional disease with or without microscopic 
residual disease.
iii. Incomplete resection with gross residual disease.
iv. Metastatic disease. 
Groups iii and iv have the worst outlook and around 50% 
of RMS patients die following chemotherapy one year or 
so after histopathological diagnosis.[2, 6]
The diagnosis of RMS is usually confirmed by 
histopathology while other investigations such as MRI 
are used to evaluate the primary lesion and to rule out 
metastatic disease. CT Scan may be useful to determine 
bony erosion of the skull but the later (MRI) is superior in 
assessment of chest metastasis.
Ultrasound of neck in our patient showed cervical lymph 
nodes suggestive of metastasis. 
Prognosis
Although the prognosis of this tumour used to be 
extremely poor (approximately 10% of patients survived 
five years), marked improvement in the survival rates has 
been reported over the past 30 years, particularly with 
the introduction of multi-modality therapy, in which 
surgery, multi-agent chemotherapy and radiotherapy have 
been combined.[11] Several factors may contribute to poor 
prognosis of the tumour such as old age, delayed diagnosis, 
and lack of understanding by the family as in our case.[14] 
Treatment, therefore, is by a multidisciplinary approach, 
consisting of surgical removal of the tumour followed by 
multi-agent chemotherapy with or without radiotherapy 
since RMS tends to metastasize to bone marrow.[12]
Conclusion
In paediatrics the presentation of RMS mimics 
complicated CSOM and hence may delay diagnosis. So, 
this rare tumour should always be suspected. A thorough 
evaluation and assessment is mandatory as it determines 
the management modalities mentioned to improve 
survival rates among patients. 
The parents consented to publication of this case including 
the photographs (taken by Dr Justin Rubena Lumaya) 
and there is no conflict of interest in this case report.
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